KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Equity Ratio (2016 - 2026)

Medtronic's Equity Ratio history spans 12 years, with the latest figure at 0.54 for Q1 2026.

  • For Q1 2026, Equity Ratio fell 2.9% year-over-year to 0.54; the TTM value through Jan 2026 reached 0.54, down 2.9%, while the annual FY2024 figure was 0.56, 1.36% down from the prior year.
  • Equity Ratio for Q1 2026 was 0.54 at Medtronic, roughly flat from 0.53 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.59 in Q3 2022 and bottomed at 0.53 in Q3 2025.
  • The 5-year median for Equity Ratio is 0.56 (2022), against an average of 0.56.
  • The largest YoY upside for Equity Ratio was 4.75% in 2024 against a maximum downside of 5.63% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.56 in 2022, then increased by 2.69% to 0.57 in 2023, then dropped by 5.63% to 0.54 in 2024, then dropped by 1.14% to 0.53 in 2025, then increased by 0.11% to 0.54 in 2026.
  • Per Business Quant, the three most recent readings for MDT's Equity Ratio are 0.54 (Q1 2026), 0.53 (Q4 2025), and 0.53 (Q3 2025).